SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-12-000058
Filing Date
2012-03-13
Accepted
2012-03-13 19:44:03
Documents
1
Period of Report
2012-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3427
  Complete submission text file 0001232524-12-000058.txt   4870
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
WILSON KAREN J (Reporting) CIK: 0001267490 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 12688569